ID: ALA5287057

Max Phase: Preclinical

Molecular Formula: C28H24N2Se

Molecular Weight: 467.47

Associated Items:

Representations

Canonical SMILES:  CCc1ccccc1-n1c(=[Se])n(C(c2ccccc2)c2ccccc2)c2ccccc21

Standard InChI:  InChI=1S/C28H24N2Se/c1-2-21-13-9-10-18-24(21)29-25-19-11-12-20-26(25)30(28(29)31)27(22-14-5-3-6-15-22)23-16-7-4-8-17-23/h3-20,27H,2H2,1H3

Standard InChI Key:  SUSNEUSZWHDEMB-UHFFFAOYSA-N

Associated Targets(non-human)

Aspergillus niger 16508 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 467.47Molecular Weight (Monoisotopic): 468.1105AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Chuai H, Zhang SQ, Bai H, Li J, Wang Y, Sun J, Wen E, Zhang J, Xin M..  (2021)  Small molecule selenium-containing compounds: Recent development and therapeutic applications.,  223  [PMID:34217061] [10.1016/j.ejmech.2021.113621]

Source